The increasing demand for precise immunological research and therapeutic development has spurred significant advances in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using multiple expression platforms, including microbial hosts, higher cell populations, and inse